Better butter, cleaner diesel, biotech firms seeking Aussie capital – weekend round-up
Back to: Blog - Technology & Science
Wellington
Wellington
Butter shaped to fit could be the catch-cry of Hamilton based company
Fonterra’s one of the first customers for Ballance Agri-Nutrients just launched
A couple of Kiwi biotech firms are to be among 40 Australasian companies pitching at a Melbourneinvestment summit as part of AusBiotech 2010 conference. The NZ Herald reports that public unlisted
Innate Therapeutics
needs $13-$20m over the next12-15 months to complete phase-2b trilas of its immunomodulator microparticle technology, designedto treat progressive forms of multiple sclerosis (MS).
LivingCell Technologies
(LCT) which will showcase its treatments for diabetes and neurologicaldisorders, is also carrying out phase-2 trials of its Diabecell product. The fully story isavailable